A detailed history of Cary Street Partners Investment Advisory LLC transactions in Amgen Inc stock. As of the latest transaction made, Cary Street Partners Investment Advisory LLC holds 12,249 shares of AMGN stock, worth $3.23 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
12,249
Previous 10,908 12.29%
Holding current value
$3.23 Million
Previous $3.41 Million 15.79%
% of portfolio
0.15%
Previous 0.14%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$309.38 - $337.38 $414,878 - $452,426
1,341 Added 12.29%
12,249 $3.95 Million
Q2 2024

Jul 22, 2024

BUY
$262.75 - $319.31 $393,599 - $478,326
1,498 Added 15.92%
10,908 $3.41 Million
Q1 2024

Apr 30, 2024

BUY
$268.87 - $324.56 $46,245 - $55,824
172 Added 1.86%
9,410 $2.68 Million
Q4 2023

Feb 07, 2024

BUY
$255.7 - $288.46 $2.06 Million - $2.32 Million
8,048 Added 676.3%
9,238 $2.66 Million
Q4 2023

Feb 05, 2024

SELL
$255.7 - $288.46 $1.91 Million - $2.15 Million
-7,464 Reduced 86.25%
1,190 $342,000
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $53,131 - $65,964
243 Added 2.89%
8,654 $2.33 Million
Q2 2023

Aug 10, 2023

SELL
$214.27 - $253.37 $3,214 - $3,800
-15 Reduced 0.18%
8,411 $1.87 Million
Q1 2023

May 12, 2023

BUY
$225.79 - $275.2 $55,995 - $68,249
248 Added 3.03%
8,426 $2.04 Million
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $44,889 - $57,037
196 Added 2.46%
8,178 $2.15 Million
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $503,688 - $568,068
2,244 Added 39.11%
7,982 $1.8 Million
Q2 2022

Aug 15, 2022

BUY
$230.71 - $256.74 $988,592 - $1.1 Million
4,285 Added 294.91%
5,738 $1.4 Million
Q1 2022

May 16, 2022

BUY
$219.27 - $242.57 $57,668 - $63,795
263 Added 22.1%
1,453 $351,000
Q4 2021

Feb 14, 2022

SELL
$198.88 - $227.6 $16,308 - $18,663
-82 Reduced 6.45%
1,190 $268,000
Q3 2021

Nov 15, 2021

SELL
$212.27 - $248.7 $3,184 - $3,730
-15 Reduced 1.17%
1,272 $270,000
Q2 2021

Aug 16, 2021

BUY
$233.58 - $259.14 $5,839 - $6,478
25 Added 1.98%
1,287 $314,000
Q1 2021

May 17, 2021

SELL
$221.91 - $258.6 $884,755 - $1.03 Million
-3,987 Reduced 75.96%
1,262 $314,000
Q4 2020

Feb 12, 2021

SELL
$216.38 - $257.67 $1.05 Million - $1.25 Million
-4,858 Reduced 48.07%
5,249 $1.21 Million
Q3 2020

Nov 12, 2020

BUY
$234.65 - $260.95 $2.08 Million - $2.31 Million
8,848 Added 702.78%
10,107 $2.57 Million
Q2 2020

Aug 05, 2020

SELL
$197.81 - $242.74 $28,286 - $34,711
-143 Reduced 10.2%
1,259 $296,000
Q1 2020

Apr 21, 2020

SELL
$182.24 - $241.7 $38,088 - $50,515
-209 Reduced 12.97%
1,402 $284,000
Q4 2019

Feb 10, 2020

BUY
$189.21 - $243.2 $304,817 - $391,795
1,611 New
1,611 $388,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Cary Street Partners Investment Advisory LLC Portfolio

Follow Cary Street Partners Investment Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cary Street Partners Investment Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cary Street Partners Investment Advisory LLC with notifications on news.